| Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 48.79B | 49.14B | 49.05B | 44.81B | 39.35B | 35.59B |
| Gross Profit | 13.42B | 13.17B | 12.73B | 10.41B | 9.89B | 8.76B |
| EBITDA | 5.02B | 5.09B | 5.31B | 3.23B | 3.17B | 7.57B |
| Net Income | 2.62B | 2.46B | 2.55B | 1.17B | 1.14B | 4.22B |
Balance Sheet | ||||||
| Total Assets | 70.79B | 70.17B | 72.39B | 69.56B | 68.42B | 69.41B |
| Cash, Cash Equivalents and Short-Term Investments | 8.68B | 8.93B | 8.78B | 7.01B | 6.79B | 7.67B |
| Total Debt | 11.25B | 10.65B | 13.57B | 14.96B | 16.22B | 17.86B |
| Total Liabilities | 30.96B | 29.60B | 34.09B | 34.49B | 34.42B | 36.45B |
| Stockholders Equity | 39.05B | 39.84B | 37.62B | 34.46B | 33.41B | 32.41B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 3.87B | 3.42B | 1.59B | 1.02B | -805.00M |
| Operating Cash Flow | 0.00 | 4.65B | 4.17B | 2.67B | 2.07B | 2.76B |
| Investing Cash Flow | 0.00 | -815.00M | -580.00M | -821.00M | -917.00M | 3.30B |
| Financing Cash Flow | 0.00 | -3.75B | -1.88B | -1.67B | -2.13B | -2.59B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
80 Outperform | ¥30.14B | 11.94 | ― | 3.98% | 3.03% | 160.39% | |
80 Outperform | ¥41.98B | 12.46 | ― | 2.46% | 2.47% | 6.88% | |
79 Outperform | ¥35.81B | 13.67 | ― | 3.89% | -2.97% | 18.38% | |
78 Outperform | ¥300.26B | 18.38 | ― | 1.52% | 5.99% | 38.18% | |
67 Neutral | ¥7.67B | 17.39 | ― | 2.92% | -2.87% | -19.37% | |
61 Neutral | $18.38B | 12.79 | -2.54% | 3.03% | 1.52% | -15.83% | |
61 Neutral | ¥2.59T | 31.11 | 34.14% | 0.59% | 20.12% | 43.82% |